中文字幕久久不卡_国产成人二三视频_在线亚洲欧美久草_久久人人超碰九七_亚洲无码欧洲色图

159-2642-3062 027-65317797
服務熱線(工作日:9:00-17:30)

瀏覽量: 209

  • 產(chǎn)品名稱: Research Grade Ustekinumab ( 烏司奴單抗 )
  • 產(chǎn)品貨號: CSD00100
  • 貨期: 現(xiàn)貨
  • 價格與訂購: 600
  • 數(shù)量:
    庫存: 100
  • 規(guī)格: 100μg 1mg
  • 產(chǎn)品信息
  • 如何訂購
    貨號(Catalog No.)
    CSD00100
    通用名INN
    Ustekinumab
    純度(Purity)
    >95%
    濃度( Concentration)
    1mg/ml
    Formulation
    PBS buffer PH7.5
    Source
    CHO cells
    內(nèi)毒素(Endotoxin level)
    Please contact with the lab for this information.
    產(chǎn)品描述(Description)
    Ustekinumab is a human immunoglobulin (Ig) G1 kappa monoclonal antibody directed against interleukin(IL)-12 and IL-23, which are cytokines that are involved in immune and inflammatory responses.2 It was generated via recombinant human IL-12 immunization of human Ig (hu-Ig) transgenic mice.2 It is a targeted biologic disease-modifying anti-rheumatic drug (bDMARDs) that is used in the management of various inflammatory conditions that involve the activation of IL-12 and IL-23 signalling pathways.Interleukin (IL)-12 and IL-23 are heterodimeric cytokines that evoke immune and inflammatory responses, such as natural killer cell activation and CD4+ T-cell differentiation and activation.The role of IL-12 and IL-23 were implicated in a variety of chronic inflammatory conditions, such as psoriasis and inflammatory bowel diseases. They modulate lymphocyte function, including T-helper (Th) 1 and Th17 cell subsets,2 as CD4+ T cells can differentiate into T-helper (Th) effector lineages based on the environment. Th cells can further activate the downstream pro-inflammatory mediators and transcription factors such as TNFα and IFNγ that drive innate and adaptive immunity.
    別名(Alternative names)
    CNTO 1275,TT-20
    靶點;物種(Specificity target name;species)
    IL12B[Homo sapiens]
    活性研究(體外/體內(nèi)研究)(Activity in vitro)
    Ustekinumab is a human monoclonal antibody that prevents human IL-12 and IL-23 from binding to the IL-12Rβ1 receptor chain of IL-12 (IL-12Rβ1/β2) and IL-23 (IL-12Rβ1/23R) receptor complexes on the surface of natural killer cells and T-cells. Ustekinumab is a human IgG1 kappa (κ) monoclonal antibody against the IL-12/IL-23 p40 subunit that prevents its interaction with IL-12Rβ1, thereby blocking subsequent signaling. The FcRn affinities at pH 6.0 fell in a narrow range for all 11 antibodies. The equilibrium dissociation constant (KD) is calculated relative to Ustekinumab (Ustekinumab=1.0).
    種類(Species)
    Homo sapiens
    受體鑒定(Receptor identification)
    IgG1-kappa
    分子量(MV)
    148000.00 Da
    CAS
    815610-63-0
    存儲條件(Storage)
    Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
    Store at +4°C short term (1-2 weeks).
    Store at -20 °C 12 months.
    Store at -80°C long term.
    Note
    For research use only .
谢通门县| 色达县| 耒阳市| 翁源县| 丹东市| 马公市| 衡东县| 武鸣县| 永仁县| 江安县| 禹城市| 丰城市| 崇信县| 海宁市| 房产| 台东市| 南靖县| 若羌县| 东乌珠穆沁旗| 和顺县| 柘城县| 苏州市| 遂宁市| 滨海县| 长海县| 南宫市| 台湾省| 喀喇| 保靖县| 西充县| 通化市| 西畴县| 凤城市| 沅江市| 天长市| 香河县| 金寨县| 林周县| 洛隆县| 山东| 玉门市|